115 results on '"Simmer, Femke"'
Search Results
2. The Complexity of Shapes: How the Circularity of Tumor Nodules Affects Prognosis in Colorectal Cancer
- Author
-
Brouwer, Nelleke P.M., Khan, Amjad, Bokhorst, John-Melle, Ayatollahi, Fazael, Hay, Jennifer, Ciompi, Francesco, Simmer, Femke, Hugen, Niek, de Wilt, Johannes H.W., Berger, Martin D., Lugli, Alessandro, Zlobec, Inti, Edwards, Joanne, and Nagtegaal, Iris D.
- Published
- 2024
- Full Text
- View/download PDF
3. Fully Automated Tumor Bud Assessment in Hematoxylin and Eosin-Stained Whole Slide Images of Colorectal Cancer
- Author
-
Bokhorst, John-Melle, Ciompi, Francesco, Öztürk, Sonay Kus, Oguz Erdogan, Ayse Selcen, Vieth, Michael, Dawson, Heather, Kirsch, Richard, Simmer, Femke, Sheahan, Kieran, Lugli, Alessandro, Zlobec, Inti, van der Laak, Jeroen, and Nagtegaal, Iris D.
- Published
- 2023
- Full Text
- View/download PDF
4. Metastasis in the gallbladder: does literature reflect reality?
- Author
-
de Bitter, Tessa J. J., Trapman, Daan M., Simmer, Femke, Hugen, Niek, de Savornin Lohman, Elise A. J., de Reuver, Philip R., Verheij, Joanne, Nagtegaal, Iris D., and van der Post, Rachel S.
- Published
- 2022
- Full Text
- View/download PDF
5. Comprehensive clinicopathological and genomic profiling of gallbladder cancer reveals actionable targets in half of patients
- Author
-
de Bitter, Tessa J. J., de Reuver, Philip R., de Savornin Lohman, Elise A. J., Kroeze, Leonie I., Vink-Börger, Marianne E., van Vliet, Shannon, Simmer, Femke, von Rhein, Daniel, Jansen, Erik A. M., Verheij, Joanne, van Herpen, Carla M. L., Nagtegaal, Iris D., Ligtenberg, Marjolijn J. L., and van der Post, Rachel S.
- Published
- 2022
- Full Text
- View/download PDF
6. Unraveling the routes to distant metastases in colorectal cancer: Tumor deposits and lymph node metastases as the gateway.
- Author
-
Brouwer, Nelleke Pietronella Maria, Oguz Erdogan, Ayse Selcen, van Vliet, Shannon, Rutgers, Natasja, Knijn, Nikki, van Lijnschoten, Gesina, Tan, Jessica Juliana, de Wilt, Johannes Hendrik Willem, Hugen, Niek, Brown, Gina, Simmer, Femke, and Nagtegaal, Iris Dionne
- Published
- 2024
- Full Text
- View/download PDF
7. Two types of primary mucinous ovarian tumors can be distinguished based on their origin
- Author
-
Simons, Michiel, Simmer, Femke, Bulten, Johan, Ligtenberg, Marjolijn J., Hollema, Harry, van Vliet, Shannon, de Voer, Richarda M., Kamping, Eveline J., van Essen, Dirk F., Ylstra, Bauke, Schwartz, Lauren E., Wang, Yihong, Massuger, Leon F., Nagtegaal, Iris D., and Kurman, Robert J.
- Published
- 2020
- Full Text
- View/download PDF
8. Type of preoperative therapy and stage-specific survival after surgery for rectal cancer: a nationwide population-based cohort study
- Author
-
Bosch, Steven L., Verhoeven, Rob H. A., Lemmens, Valery E. P. P., Simmer, Femke, Poortmans, Philip, de Wilt, Johannes H. W., and Nagtegaal, Iris D.
- Published
- 2019
- Full Text
- View/download PDF
9. Transcriptomics and proteomics reveal distinct biology for lymph node metastases and tumour deposits in colorectal cancer.
- Author
-
Brouwer, Nelleke PM, Webbink, Loth, Haddad, Tariq S, Rutgers, Natasja, van Vliet, Shannon, Wood, Colin S, Jansen, Pascal WTC, Lafarge, Maxime W, de Wilt, Johannes HW, Hugen, Niek, Simmer, Femke, Jamieson, Nigel B, Tauriello, Daniele VF, Kölzer, Viktor H, Vermeulen, Michiel, and Nagtegaal, Iris D
- Subjects
LYMPHATIC metastasis ,COLORECTAL cancer ,GENE expression ,BIOLOGY ,PROTEOMICS - Abstract
Both lymph node metastases (LNMs) and tumour deposits (TDs) are included in colorectal cancer (CRC) staging, although knowledge regarding their biological background is lacking. This study aimed to compare the biology of these prognostic features, which is essential for a better understanding of their role in CRC spread. Spatially resolved transcriptomic analysis using digital spatial profiling was performed on TDs and LNMs from 10 CRC patients using 1,388 RNA targets, for the tumour cells and tumour microenvironment. Shotgun proteomics identified 5,578 proteins in 12 different patients. Differences in RNA and protein expression were analysed, and spatial deconvolution was performed. Image‐based consensus molecular subtype (imCMS) analysis was performed on all TDs and LNMs included in the study. Transcriptome and proteome profiles identified distinct clusters for TDs and LNMs in both the tumour and tumour microenvironment segment, with upregulation of matrix remodelling, cell adhesion/motility, and epithelial–mesenchymal transition (EMT) in TDs (all p < 0.05). Spatial deconvolution showed a significantly increased abundance of fibroblasts, macrophages, and regulatory T‐cells (p < 0.05) in TDs. Consistent with a higher fibroblast and EMT component, imCMS classified 62% of TDs as poor prognosis subtype CMS4 compared to 36% of LNMs (p < 0.05). Compared to LNMs, TDs have a more invasive state involving a distinct tumour microenvironment and upregulation of EMT, which are reflected in a more frequent histological classification of TDs as CMS4. These results emphasise the heterogeneity of locoregional spread and the fact that TDs should merit more attention both in future research and during staging. © 2023 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
10. Sequencing of RAS/RAF pathway genes in primary colorectal cancer and matched liver and lung metastases
- Author
-
Knijn, Nikki, van de Water, Carlijn, van Vliet, Shannon, Meijer, Jos, Riemersma, Sietske, Tebar, Maria, Punt, Cornelis, Mekenkamp, Leonie, Simmer, Femke, and Nagtegaal, Iris
- Published
- 2019
- Full Text
- View/download PDF
11. Partially methylated domains are hypervariable in breast cancer and fuel widespread CpG island hypermethylation
- Author
-
Brinkman, Arie B., Nik-Zainal, Serena, Simmer, Femke, Rodríguez-González, F. Germán, Smid, Marcel, Alexandrov, Ludmil B., Butler, Adam, Martin, Sancha, Davies, Helen, Glodzik, Dominik, Zou, Xueqing, Ramakrishna, Manasa, Staaf, Johan, Ringnér, Markus, Sieuwerts, Anieta, Ferrari, Anthony, Morganella, Sandro, Fleischer, Thomas, Kristensen, Vessela, Gut, Marta, van de Vijver, Marc J., Børresen-Dale, Anne-Lise, Richardson, Andrea L., Thomas, Gilles, Gut, Ivo G., Martens, John W. M., Foekens, John A., Stratton, Michael R., and Stunnenberg, Hendrik G.
- Published
- 2019
- Full Text
- View/download PDF
12. Appraisal of the PathoDiscovery: an interactive web‐based educational tool for teaching pathophysiology and histopathology.
- Author
-
Buma, Alessandra I.G., Simmer, Femke, den Braber‐Ymker, Marjanne, and Groenen, Patricia J.T.A.
- Subjects
- *
MEDICAL students , *BLENDED learning , *PSYCHOLOGY of students , *PATHOLOGICAL physiology , *HISTOPATHOLOGY , *PSYCHOLOGICAL feedback - Abstract
Virtual pathology education has shown to enhance the students' learning experience. At the Radboud University, an E‐learning platform—called the "PathoDiscovery"—was developed and first used in a course about neoplasm development amongst first year (bio)medical sciences students. The PathoDiscovery incorporates high‐power microscopic images, histological annotations, interactive questions and pre‐programmed feedback.The objective of our study was to develop and evaluate the PathoDiscovery within the "Neoplasm" course focusing on student perceptions of usability and utility. For this study the online feedback on the PathoDiscovery that was obtained anonymously from (bio)medical students over two consecutive academic years was analyzed. The responses of the first year were used to make improvements. After the second year, the feedback of the two academic years was compared. The rating of the E‐learning increased from 6.8 (n = 285) to 7.4 (n = 247) after implementation of feedback obtained in the first year. The students judged the structure as logical (90%). The content was considered easy or just right (57%), matched the learning objectives (76%), and contributed to knowledge development (78%). We conclude that the first experiences with the PathoDiscovery are positive for both students and lecturers; it is an example of a dynamic online learning tool that is easily adaptable and is well suited for a blended learning approach. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
13. Pseudobudding: ruptured glands do not represent true tumor buds.
- Author
-
Haddad, Tariq Sami, van den Dobbelsteen, Luuk, Öztürk, Sonay K, Geene, Robin, Nijman, Isaäc J, Verrijp, Kiek, Jamieson, Nigel B, Wood, Colin, van Vliet, Shannon, Reuvers, Luuk, Achouiti, Soumia, Rutgers, Natasja, Brouwer, Nelleke, Simmer, Femke, Zlobec, Inti, Lugli, Alessandro, and Nagtegaal, Iris D
- Subjects
TUMOR budding ,GLANDS ,EPITHELIAL-mesenchymal transition ,EXTRACELLULAR matrix ,COLORECTAL cancer - Abstract
Tumor budding (TB) is a strong biomarker of poor prognosis in colorectal cancer and other solid cancers. TB is defined as isolated single cancer cells or clusters of up to four cancer cells at the invasive tumor front. In areas with a large inflammatory response at the invasive front, single cells and cell clusters surrounding fragmented glands are observed appearing like TB. Occurrence of these small groups is referred to as pseudobudding (PsB), which arises due to external influences such as inflammation and glandular disruption. Using a combination of orthogonal approaches, we show that there are clear biological differences between TB and PsB. TB is representative of active invasion by presenting features of epithelial‐mesenchymal transition and exhibiting increased deposition of extracellular matrix within the surrounding tumor microenvironment (TME), whereas PsB represents a reactive response to heavy inflammation where increased levels of granulocytes within the surrounding TME are observed. Our study provides evidence that areas with a strong inflammatory reaction should be avoided in the routine diagnostic assessment of TB. © 2023 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
14. Clonal Patterns Between Pouch Neoplasia and Prior Colorectal Neoplasia in Inflammatory Bowel Disease Patients: An Exploratory Cohort Study.
- Author
-
Groen, Maarten te, Derikx, Lauranne A A P, Lierop, Lisa van, Ylstra, Bauke, Hoentjen, Frank, Nagtegaal, Iris D, and Simmer, Femke
- Published
- 2023
- Full Text
- View/download PDF
15. Semi-Supervised Learning to Automate Tumor Bud Detection in Cytokeratin-Stained Whole-Slide Images of Colorectal Cancer.
- Author
-
Bokhorst, John-Melle, Nagtegaal, Iris D., Zlobec, Inti, Dawson, Heather, Sheahan, Kieran, Simmer, Femke, Kirsch, Richard, Vieth, Michael, Lugli, Alessandro, van der Laak, Jeroen, and Ciompi, Francesco
- Subjects
DEEP learning ,EARLY detection of cancer ,COLORECTAL cancer ,LEARNING strategies ,TUMOR markers ,ARTIFICIAL neural networks - Abstract
Simple Summary: Tumor budding is a promising and cost-effective histological biomarker with strong prognostic value in colorectal cancer. It is defined by the presence of single tumor cells or small clusters of cells within the tumor or at the tumor-invasion front. Deep learning based tumor bud assessment can potentially improve diagnostic reproducibility and efficiency. This study aimed to develop a deep learning algorithm to detect tumor buds in cytokeratin-stained images automatically. We used a semi-supervised learning technique to overcome the limitations of a small dataset. Validation of our model showed a sensitivity of 91% and a fairly strong correlation between a human annotator and our deep learning method. We demonstrate that the automated tumor bud count achieves a prognostic value similar to visual estimation. We also investigate new metrics for quantifying buds, such as density and dispersion, and report on their predictive value. Tumor budding is a histopathological biomarker associated with metastases and adverse survival outcomes in colorectal carcinoma (CRC) patients. It is characterized by the presence of single tumor cells or small clusters of cells within the tumor or at the tumor-invasion front. In order to obtain a tumor budding score for a patient, the region with the highest tumor bud density must first be visually identified by a pathologist, after which buds will be counted in the chosen hotspot field. The automation of this process will expectedly increase efficiency and reproducibility. Here, we present a deep learning convolutional neural network model that automates the above procedure. For model training, we used a semi-supervised learning method, to maximize the detection performance despite the limited amount of labeled training data. The model was tested on an independent dataset in which human- and machine-selected hotspots were mapped in relation to each other and manual and machine detected tumor bud numbers in the manually selected fields were compared. We report the results of the proposed method in comparison with visual assessment by pathologists. We show that the automated tumor bud count achieves a prognostic value comparable with visual estimation, while based on an objective and reproducible quantification. We also explore novel metrics to quantify buds such as density and dispersion and report their prognostic value. We have made the model available for research use on the grand-challenge platform. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
16. Synthetic Heterochromatin Bypasses RNAi and Centromeric Repeats to Establish Functional Centromeres
- Author
-
Kagansky, Alexander, Folco, Hernan Diego, Almeida, Ricardo, Pidoux, Alison L., Boukaba, Abdelhalim, Simmer, Femke, Urano, Takeshi, Hamilton, Georgina L., and Allshire, Robin C.
- Published
- 2009
- Full Text
- View/download PDF
17. PML-RARα/RXR Alters the Epigenetic Landscape in Acute Promyelocytic Leukemia
- Author
-
Martens, Joost H.A., Brinkman, Arie B., Simmer, Femke, Francoijs, Kees-Jan, Nebbioso, Angela, Ferrara, Felicetto, Altucci, Lucia, and Stunnenberg, Hendrik G.
- Published
- 2010
- Full Text
- View/download PDF
18. On the role of RNA amplification in dsRNA-triggered gene silencing
- Author
-
Sijen, Titia, Fleenor, Jamie, Simmer, Femke, Thijssen, Karen L., Parrish, Susan, Timmons, Lisa, Plasterk, Ronald H. A., and Fire, Andrew
- Subjects
Cell research -- Analysis ,Messenger RNA -- Genetic aspects ,Caenorhabditis elegans -- Physiological aspects ,Genetic translation -- Physiological aspects ,Brain research -- Analysis ,Carrier proteins -- Physiological aspects ,Biological sciences - Abstract
Research has been conducted on the trigger RNA amplification. The effect of this amplification on the RNA interference in Caenorhabditis elegans has been investigated and the results indicate that the amplification mechanism augments the RNA interference-based surveillance potency.
- Published
- 2001
19. RDE-2 interacts with MUT-7 to mediate RNA interference in Caenorhabditis elegans
- Author
-
Tops, Bastiaan B. J., Tabara, Hiroaki, Sijen, Titia, Simmer, Femke, Mello, Craig C., Plasterk, Ronald H. A., and Ketting, René F.
- Published
- 2005
20. Umbilical metastases: Real‐world data shows abysmal outcome.
- Author
-
Hugen, Niek, Kanne, Heleen, Simmer, Femke, Water, Carlijn, Voorham, Quirinus J., Ho, Vincent K., Lemmens, Valery E., Simons, Michiel, and Nagtegaal, Iris D.
- Subjects
PROGNOSIS ,OVERALL survival ,SURVIVAL rate ,PROPORTIONAL hazards models ,METASTASIS - Abstract
Umbilical metastases form a clinical challenge, especially when they represent the first sign of malignant disease and the primary tumor is unknown. Our study aims to generate insight into the origin and timing of umbilical metastasis, as well as patient survival, using population‐based data. A nationwide review of pathology records of patients diagnosed with an umbilical metastasis between 1979 and 2015 was performed. Data was collected from the Nationwide Network and Registry of Histopathology and Cytopathology (PALGA) and the Netherlands Cancer Registry. Kaplan‐Meier analyses and log‐rank testing were used to estimate overall survival and a Cox proportional hazard model was used to determine multivariable hazard ratios. A total of 806 patients with an umbilical metastasis were included. There were 210 male (26.1%) and 596 female (73.9%) patients. Distribution of umbilical metastases was different between male and female patients due to the high incidence of umbilical metastases originating from the ovaries in females. They most frequently originated from the ovaries in female patients (38.8%) and from the colon in male patients (43.8%). In 18% of cases no primary tumor could be identified. Prognosis after diagnosis of an umbilical metastasis was dismal with a median survival of 7.9 months (95% confidence interval 6.7‐9.1). The origin of the primary tumor was an independent prognostic factor for overall survival. In conclusion, umbilical metastases relatively rare, mainly originating from intraabdominal primary tumors. Survival is dependent on the origin of the primary tumor and poor overall survival rates warrant early recognition. What's new? Umbilical metastases are a rare consequence of malignant disease that pose unique clinical challenges. Very little is known about these metastases, especially regarding incidence and survival. This population‐based analysis of more than 800 patients in the Netherlands shows that the distribution in umbilical metastases differs between males and females. In females, metastases most commonly originated from the ovaries, while in males, the colon was most common. Umbilical metastases, however, were linked to a variety of primary tumors and were frequently diagnosed synchronously with the primary tumor. While prognosis was poor overall, survival was influenced by primary tumor origin. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
21. Improving tumor budding reporting in colorectal cancer: a Delphi consensus study.
- Author
-
Haddad, Tariq Sami, Lugli, Alessandro, Aherne, Susan, Barresi, Valeria, Terris, Benoît, Bokhorst, John-Melle, Brockmoeller, Scarlet Fiona, Cuatrecasas, Miriam, Simmer, Femke, El-Zimaity, Hala, Fléjou, Jean-François, Gibbons, David, Cathomas, Gieri, Kirsch, Richard, Kuhlmann, Tine Plato, Langner, Cord, Loughrey, Maurice B., Riddell, Robert, Ristimäki, Ari, and Kakar, Sanjay
- Abstract
Tumor budding is a long-established independent adverse prognostic marker in colorectal cancer, yet methods for its assessment have varied widely. In an effort to standardize its reporting, a group of experts met in Bern, Switzerland, in 2016 to reach consensus on a single, international, evidence-based method for tumor budding assessment and reporting (International Tumor Budding Consensus Conference [ITBCC]). Tumor budding assessment using the ITBCC criteria has been validated in large cohorts of cancer patients and incorporated into several international colorectal cancer pathology and clinical guidelines. With the wider reporting of tumor budding, new issues have emerged that require further clarification. To better inform researchers and health-care professionals on these issues, an international group of experts in gastrointestinal pathology participated in a modified Delphi process to generate consensus and highlight areas requiring further research. This effort serves to re-affirm the importance of tumor budding in colorectal cancer and support its continued use in routine clinical practice. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
22. RNF43 mutation analysis in serrated polyposis, sporadic serrated polyps and Lynch syndrome polyps.
- Author
-
Herwaarden, Yasmijn J, Koggel, Lieke M, Simmer, Femke, Vink‐Börger, Elisa M., Dura, Polat, Meijer, Gerrit A, Nagengast, Fokko M, Hoogerbrugge, Nicoline, Bisseling, Tanya M, and Nagtegaal, Iris D
- Subjects
HEREDITARY nonpolyposis colorectal cancer ,ADENOMATOUS polyps ,UBIQUITIN ligases ,COLORECTAL cancer ,SOMATIC mutation ,FRAMESHIFT mutation ,ADENOMA - Abstract
Aims: RNF43 is suggested to be involved in the serrated pathway towards colorectal cancer and encodes a transmembrane Ring‐type E3 ubiquitin ligase that negatively regulates the Wnt pathway. This study aimed to elucidate the role of RNF43 gene variants in serrated polyposis syndrome (SPS) and serrated polyps. Methods and results: Three cohorts were tested. The first cohort included germline DNA of 26 SPS patients tested for pathogenic variants in RNF43 by Sanger sequencing all exons. In the second cohort we tested somatic DNA for RNF43 mutations from sporadic serrated lesions: 25 hyperplastic polyps, 35 sessile serrated lesions and 38 traditional serrated adenomas (TSA). In the third cohort we investigated RNF43 mutations in 49 serrated polyps and 60 conventional adenomas from 40 patients with Lynch syndrome. No germline RNF43 pathogenic variants were detected in our SPS cohort. In sporadic colorectal lesions we detected RNF43 deleterious frameshift mutations in three TSA and one SSL. The RNF43 mutations in previously described homopolymeric hot‐spots were detected in microsatellite‐instable (MSI) polyps and the other RNF43 mutations in microsatellite‐stable (MSS) serrated polyps. RNF43 hot‐spot mutations were discovered in seven serrated polyps and 12 conventional adenomas from Lynch patients. Conclusion: Truncating germline RNF43 mutations are uncommon in SPS patients. Somatic mutations in RNF43 were found in sporadic TSA and SSL and both serrated polyps and adenomas from Lynch syndrome patients, suggesting that they do not develop early in the pathway to CRC and are not specific for serrated polyp subtypes. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
23. Colorectal metastasis to the gallbladder mimicking a primary gallbladder malignancy: histopathological and molecular characteristics.
- Author
-
Bitter, Tessa J J, Linden, Ragna L A, Vliet, Shannon, Weren, Fieke, Sie, Daoud, Ylstra, Bauke, Linden, Hans C, Knijn, Nikki, Ligtenberg, Marjolijn J L, Post, Rachel S, Simmer, Femke, and Nagtegaal, Iris D
- Subjects
GALLBLADDER cancer ,GALLBLADDER ,SOMATIC mutation ,COLON cancer ,METASTASIS ,NATIONAL archives - Abstract
Aims: Outcomes of colorectal cancer (CRC) treatment and survival have steadily improved during the past decades, accompanied by an increased risk of developing second primary tumours and metastatic tumours at unusual sites. Metastatic CRC can show mucosal colonisation, thereby mimicking a second primary tumour. This potential confusion could lead to incorrect diagnosis and consequently inadequate treatment of the patient. The aim of this study was to differentiate between metastatic CRC and a second primary (gallbladder cancer, GBC) using a combination of standard histopathology and molecular techniques. Methods and results: Ten consecutive patients with both CRC and GBC were identified in our region using the Dutch National Pathology Archive (PALGA). Two patients served as negative controls. Histology of GBC was reviewed by nine pathologists. A combination of immunohistochemistry, microsatellite analysis, genomewide DNA copy number analysis and targeted somatic mutation analysis was used to aid in differential diagnosis. In two patients, CRC and GBC were clonally related, as confirmed by somatic mutation analysis. For one case, this was confirmed by genomewide DNA copy number analysis. However, in both cases, pathologists initially considered the GBC as a second primary tumour. Conclusions: Metastatic CRC displaying mucosal colonisation is often misinterpreted as a second primary tumour. A combination of traditional histopathology and molecular techniques improves this interpretation, and lowers the risk of inadequate treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
24. Multifocal Colorectal Cancer—Do Intraluminal Metastases Occur?
- Author
-
Simmer, Femke, van der Linden, Ragna L.A., Ligtenberg, Marjolijn J.L., Ylstra, Bauke, van der Post, Rachel S., and Nagtegaal, Iris D.
- Published
- 2021
- Full Text
- View/download PDF
25. The G-Protein [Beta]-Subunit GPB-2 in Caenorhabditis elegans Regulates the [G.sub.o][Alpha]-[G.sub.q][Alpha] Signaling Network Through Interactions With the Regulator of G-Protein Signaling Proteins EGL-10 and EAT-16
- Author
-
van der Linden, Alexander M., Simmer, Femke, Cuppen, Edwin, and Plasterk, Ronald H. A.
- Subjects
Caenorhabditis elegans -- Genetic aspects ,G proteins -- Analysis ,Cellular signal transduction -- Genetic aspects ,Neural circuitry -- Analysis ,Biological sciences - Abstract
The genome of Caenorhabditis elegans harbors two genes for G-protein [Beta]-subunits. Here, we describe the characterization of the second G-protein [Beta]-subunit gene gpb-2. In contrast to gpb-1, gpb-2 is not an essential gene even though, like gpb-1, gpb-2 is expressed during development, in the nervous system, and in muscle cells. A loss-of-function mutation in gpb-2 produces a variety of behavioral defects, including delayed egg laying and reduced pharyngeal pumping. Genetic analysis shows that GPB-2 interacts with the GOA-1 (homologue of mammalian [G.sub.o][Alpha]) and EGL-30 (homologue of mammalian [G.sub.q][Alpha]) signaling pathways. GPB-2 is most similar to the divergent mammalian G[Beta]5 subunit, which has been shown to mediate a specific interaction with a G[Gamma]-subunit-like (GGL) domain of RGS proteins. We show here that GPB-2 physically and genetically interacts with the GGL-containing RGS proteins EGL-10 and EAT-16. Taken together, our results suggest that GPB-2 works in concert with the RGS proteins EGL-10 and EAT-16 to regulate GOA-1 ([G.sub.o][Alpha]) and EGL-30 ([G.sub.q][Alpha]) signaling.
- Published
- 2001
26. Perineural Invasion Is a Strong Prognostic Factor in Colorectal Cancer.
- Author
-
Knijn, Nikki, Mogk, Stephanie C., Teerenstra, Steven, Simmer, Femke, and Nagtegaal, Iris D.
- Published
- 2016
- Full Text
- View/download PDF
27. Regulation of DNA Methylation Patterns by CK2-Mediated Phosphorylation of Dnmt3a.
- Author
-
Deplus, Rachel, Blanchon, Loïc, Rajavelu, Arumugam, Boukaba, Abdelhalim, Defrance, Matthieu, Luciani, Judith, Rothé, Françoise, Dedeurwaerder, Sarah, Denis, Hélène, Brinkman, Arie B., Simmer, Femke, Müller, Fabian, Bertin, Benjamin, Berdasco, Maria, Putmans, Pascale, Calonne, Emilie, Litchfield, David W., de Launoit, Yvan, Jurkowski, Tomasz P., and Stunnenberg, Hendrik G.
- Abstract
DNA methylation is a central epigenetic modification that is established by de novo DNA methyltransferases. The mechanisms underlying the generation of genomic methylation patterns are still poorly understood. Using mass spectrometry and a phosphospecific Dnmt3a antibody, we demonstrate that CK2 phosphorylates endogenous Dnmt3a at two key residues located near its PWWP domain, thereby downregulating the ability of Dnmt3a to methylate DNA. Genome-wide DNA methylation analysis shows that CK2 primarily modulates CpG methylation of several repeats, most notably of Alu SINEs. This modulation can be directly attributed to CK2-mediated phosphorylation of Dnmt3a. We also find that CK2-mediated phosphorylation is required for localization of Dnmt3a to heterochromatin. By revealing phosphorylation as a mode of regulation of de novo DNA methyltransferase function and by uncovering a mechanism for the regulation of methylation at repetitive elements, our results shed light on the origin of DNA methylation patterns. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
28. Epigenetic targeting in pancreatic cancer.
- Author
-
van Kampen, Jasmijn G.M., Marijnissen-van Zanten, Monica A.J., Simmer, Femke, van der Graaf, Winette T.A., Ligtenberg, Marjolijn J.L., and Nagtegaal, Iris D.
- Abstract
Abstract: The prognosis of pancreatic cancer patients is very poor, with a 5-year survival of less than 6%. Therefore, there is an urgent need for new therapeutic options in pancreatic cancer. In the past years it became evident that deregulation of epigenetic mechanisms plays an important role in pancreatic carcinogenesis. This review focuses on the exploitation of drugs that alter histone modifications, DNA methylation and microRNA expression as options for the treatment of pancreatic cancer. [Copyright &y& Elsevier]
- Published
- 2014
- Full Text
- View/download PDF
29. Comparative genome-wide DNA methylation analysis of colorectal tumor and matched normal tissues.
- Author
-
Simmer, Femke, Brinkman, Arie B., Assenov, Yassen, Matarese, Filomena, Kaan, Anita, Sabatino, Lina, Villanueva, Alberto, Huertas, Dori, Esteller, Manel, Lengauer, Thomas, Bock, Christoph, Colantuoni, Vittorio, Altucci, Lucia, and Stunnenberg, Hendrik G.
- Published
- 2012
- Full Text
- View/download PDF
30. Raf1 Is a DCAF for the Rik1 DDB1-Like Protein and Has Separable Roles in siRNA Generation and Chromatin Modification.
- Author
-
Buscaino, Alessia, White, Sharon A., Houston, Douglas R., Lejeune, Erwan, Simmer, Femke, Alves, Flavia de Lima, Diyora, Piyush T., Urano, Takeshi, Bayne, Elizabeth H., Rappsilber, Juri, and Allshire, Robin C.
- Subjects
SMALL interfering RNA ,CHROMATIN ,METHYLATION ,HISTONE methylation ,ANTISENSE RNA - Abstract
Non-coding transcription can trigger histone post-translational modifications forming specialized chromatin. In fission yeast, heterochromatin formation requires RNAi and the histone H3K9 methyltransferase complex CLRC, composed of Clr4, Raf1, Raf2, Cul4, and Rik1. CLRC mediates H3K9 methylation and siRNA production; it also displays E3-ubiquitin ligase activity in vitro. DCAFs act as substrate receptors for E3 ligases and may couple ubiquitination with histone methylation. Here, structural alignment and mutation of signature WDxR motifs in Raf1 indicate that it is a DCAF for CLRC. We demonstrate that Raf1 promotes H3K9 methylation and siRNA amplification via two distinct, separable functions. The association of the DCAF Raf1 with Cul4-Rik1 is critical for H3K9 methylation, but dispensable for processing of centromeric transcripts into siRNAs. Thus the association of a DCAF, Raf1, with its adaptor, Rik1, is required for histone methylation and to allow RNAi to signal to chromatin. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
31. Whole-genome DNA methylation profiling using MethylCap-seq
- Author
-
Brinkman, Arie B., Simmer, Femke, Ma, Kelong, Kaan, Anita, Zhu, Jingde, and Stunnenberg, Hendrik G.
- Subjects
- *
GENOMES , *METHYLATION , *NUCLEOTIDE sequence , *COST effectiveness , *METHYL groups , *CARRIER proteins - Abstract
Abstract: MethylCap-seq is a robust procedure for genome-wide profiling of DNA methylation. The approach consists of the capture of methylated DNA using the MBD domain of MeCP2, and subsequent next-generation sequencing of eluted DNA. Elution of the captured methylated DNA is done in steps using a salt gradient, which stratifies the genome into fractions with different CpG density. The enrichment reached within the individual eluates allows for cost-effective deep sequence coverage. The profiles together yield a detailed genome-wide map of methylated regions and readily allows detection of DNA methylation in known and novel regions. Here, we describe principles and details of the MethylCap-seq procedure using different sources of starting material. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
32. Quantitative comparison of genome-wide DNA methylation mapping technologies.
- Author
-
Bock, Christoph, Tomazou, Eleni M., Brinkman, Arie B., Müller, Fabian, Simmer, Femke, Hongcang Gu, Jäger, Natalie, Gnirke, Andreas, Stunnenberg, Hendrik G., and Meissner, Alexander
- Subjects
DNA ,METHYLATION ,GENE expression ,CELL differentiation ,GENOMICS ,CELL lines - Abstract
DNA methylation plays a key role in regulating eukaryotic gene expression. Although mitotically heritable and stable over time, patterns of DNA methylation frequently change in response to cell differentiation, disease and environmental influences. Several methods have been developed to map DNA methylation on a genomic scale. Here, we benchmark four of these approaches by analyzing two human embryonic stem cell lines derived from genetically unrelated embryos and a matched pair of colon tumor and adjacent normal colon tissue obtained from the same donor. Our analysis reveals that methylated DNA immunoprecipitation sequencing (MeDIP-seq), methylated DNA capture by affinity purification (MethylCap-seq), reduced representation bisulfite sequencing (RRBS) and the Infinium HumanMethylation27 assay all produce accurate DNA methylation data. However, these methods differ in their ability to detect differentially methylated regions between pairs of samples. We highlight strengths and weaknesses of the four methods and give practical recommendations for the design of epigenomic case-control studies. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
33. Hairpin RNA induces secondary small interfering RNA synthesis and silencing in trans in fission yeast.
- Author
-
Simmer, Femke, Buscaino, Alessia, Kos-Braun, Isabelle C, Kagansky, Alexander, Boukaba, Abdelhalim, Urano, Takeshi, Kerr, Alastair R W, and Allshire, Robin C
- Abstract
RNA interference (RNAi) is widespread in eukaryotes and regulates gene expression transcriptionally or post-transcriptionally. In fission yeast, RNAi is tightly coupled to template transcription and chromatin modifications that establish heterochromatin in cis. Exogenous double-stranded RNA (dsRNA) triggers seem to induce heterochromatin formation in trans only when certain silencing proteins are overexpressed. Here, we show that green fluorescent protein (GFP) hairpin dsRNA allows production of high levels of Argonaute-associated small interfering RNAs (siRNAs), which can induce heterochromatin formation at a remote locus. This silencing does not require any manipulation apart from hairpin expression. In cells expressing a ura4
+ –GFP fusion gene, production of GFP siRNAs causes the appearance of ura4 siRNAs from the target gene. Production of these secondary siRNAs depends on RNA-dependent RNA polymerase Rdp1 (RDRPRdp1 ) function and other RNAi pathway components. This demonstrates that transitivity occurs in fission yeast and implies that RDRPRdp1 can synthesize RNA from targeted RNA templates in vivo, generating siRNAs not homologous to the hairpin. [ABSTRACT FROM AUTHOR]- Published
- 2010
- Full Text
- View/download PDF
34. Analysis of small RNA in fission yeast; centromeric siRNAs are potentially generated through a structured RNA.
- Author
-
Djupedal, Ingela, Kos-Braun, Isabelle C., Mosher, Rebecca A., Söderholm, Niklas, Simmer, Femke, Hardcastle, Thomas J., Fender, Aurélie, Heidrich, Nadja, Kagansky, Alexander, Bayne, Elizabeth, Wagner, E. Gerhart H., Baulcombe, David C., Allshire, Robin C., and Ekwall, Karl
- Subjects
CHROMOSOMES ,HETEROCHROMATIN ,CENTROMERE ,CHROMATIN ,LEAVENING agents - Abstract
The formation of heterochromatin at the centromeres in fission yeast depends on transcription of the outer repeats. These transcripts are processed into siRNAs that target homologous loci for heterochromatin formation. Here, high throughput sequencing of small RNA provides a comprehensive analysis of centromere-derived small RNAs. We found that the centromeric small RNAs are Dcr1 dependent, carry 5′-monophosphates and are associated with Ago1. The majority of centromeric small RNAs originate from two remarkably well-conserved sequences that are present in all centromeres. The high degree of similarity suggests that this non-coding sequence in itself may be of importance. Consistent with this, secondary structure-probing experiments indicate that this centromeric RNA is partially double-stranded and is processed by Dicer in vitro. We further demonstrate the existence of small centromeric RNA in rdp1Δ cells. Our data suggest a pathway for siRNA generation that is distinct from the well-documented model involving RITS/RDRC. We propose that primary transcripts fold into hairpin-like structures that may be processed by Dcr1 into siRNAs, and that these siRNAs may initiate heterochromatin formation independent of RDRC activity. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
35. Genome-Wide RNAi of C. elegans Using the Hypersensitive rrf-3 Strain Reveals Novel Gene Functions.
- Author
-
Simmer, Femke, Moorman, Celine, van der Linden, Alexander M, Kuijk, Ewart, van den Berghe, Peter V.E, Kamath, Ravi S, Fraser, Andrew G, Ahringer, Julie, and Plasterk, Ronald H. A
- Subjects
- *
CAENORHABDITIS elegans , *DOUBLE-stranded RNA , *FUNCTIONAL genomics , *GENES , *MOLECULAR cloning - Abstract
RNA-mediated interference (RNAi) is a method to inhibit gene function by introduction of double-stranded RNA (dsRNA). Recently, an RNAi library was constructed that consists of bacterial clones expressing dsRNA, corresponding to nearly 90% of the 19,427 predicted genes of C. elegans. Feeding of this RNAi library to the standard wild-type laboratory strain Bristol N2 detected phenotypes for approximately 10% of the corresponding genes. To increase the number of genes for which a loss-of-function phenotype can be detected, we undertook a genome-wide RNAi screen using the rrf-3 mutant strain, which we found to be hypersensitive to RNAi. Feeding of the RNAi library to rrf-3 mutants resulted in additional loss-of-function phenotypes for 393 genes, increasing the number of genes with a phenotype by 23%. These additional phenotypes are distributed over different phenotypic classes. We also studied interexperimental variability in RNAi results and found persistent levels of false negatives. In addition, we used the RNAi phenotypes obtained with the genome-wide screens to systematically clone seven existing genetic mutants with visible phenotypes. The genome-wide RNAi screen using rrf-3 significantly increased the functional data on the C. elegans genome. The resulting dataset will be valuable in conjunction with other functional genomics approaches, as well as in other model organisms. The screen suggested functions for 393 genes for which no RNAi-mediated phenotype was known. The comparison with similar screens in worms has general implications for RNAi experiments. [ABSTRACT FROM AUTHOR]
- Published
- 2003
- Full Text
- View/download PDF
36. Tumour deposits are associated with worse survival than extranodal extension; a network meta‐analysis on tumour nodules in colorectal cancer.
- Author
-
Brouwer, Nelleke P M, Vliet, Shannon, IntHout, Joanna, De Wilt, Johannes H W, Simmer, Femke, Hugen, Niek, and Nagtegaal, Iris D
- Subjects
- *
LYMPHATIC metastasis , *PROGNOSIS , *COLORECTAL cancer , *OVERALL survival , *SCIENCE databases - Abstract
Lymph node metastases (LNM) play a central role in the tumour–node–metastasis (TNM) classification for colorectal cancer (CRC), with extranodal extension (ENE) as an adverse feature. ENE has never been directly compared to tumour deposits (TD). The aim of this study was to perform an up‐to‐date systematic review, including a network meta‐analysis to compare their prognostic value. A comprehensive search was conducted on PubMed, Embase, Web of Science and Cochrane databases to identify all prognostic studies on ENE and TD. A total of 20 studies were included, with 7719 cases. The primary outcome was 5‐year disease‐free survival (DFS); secondary outcomes were overall survival (OS) and disease‐specific survival (DSS). Frequentist paired and network meta‐analyses were performed using the netmeta package in R. For univariable DFS analysis, LNM + TD+ cases had a significantly worse outcome compared with LNM + ENE+ cases [hazard ratio (HR) = 1.27, 95% confidence interval (CI) = 1.06–1.53], which was no longer significant for multivariable DFS analysis (HR = 1.13, 95% CI = 0.87–1.46). All OS and multivariable DSS analyses showed a significantly worse outcome for LNM + TD+ cases compared with LNM + ENE cases. For all outcomes, both LNM + TD+ and LNM + ENE+ had a significantly increased hazard compared with LNM+ cases. This study shows that there is a trend towards worse outcome for LNM + TD+ than LNM + ENE+, not statistically significant in multivariable DFS analysis. Both groups perform significantly worse than cases with LNM only. To improve the accuracy of CRC staging, we recommend to put more emphasis on both ENE and TD in the TNM classification, with the most prominent role for TD. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
37. Intra-Tumoral Genomic Heterogeneity in Rectal Cancer: Mutational Status Is Dependent on Preoperative Biopsy Depth and Location.
- Author
-
Vuijk, Floris A., van de Water, Carlijn, Lent-van Vliet, Shannon, van der Valk, Maxime J. M., Simmer, Femke, van de Velde, Cornelis J. H., Vahrmeijer, Alexander L., Nagtegaal, Iris D., Hilling, Denise E., Ciardiello, Fortunato, and García-Olmo, Damián
- Subjects
RECTUM tumors - Abstract
Simple Summary: A subset of patients with rectal cancer are treated before surgery with chemoradiation. Unfortunately, this neoadjuvant chemoradiotherapy does not have the preferred effect of tumor downstaging in all patients, but does bring substantial side effects and possible complications. A pre-treatment prediction based on available parameters might provide a means to better select therapy for individual patients. Genomic mutational status of pre-treatment biopsies may provide prognostic information, however, it also might be influenced by tumor heterogeneity. This study investigates whether pre-treatment biopsy material is a reliable way of defining mutational status in rectal cancer. Neoadjuvant therapy before surgical resection is indicated for patients with locally advanced rectal cancer. However, a significant number of patients show minimal or no response to neoadjuvant therapy. Unfortunately, we are currently unable to predict response and identify non-responding patients before neoadjuvant treatment is given. Genomic mutational status might provide valuable prognostic information. However, it is unclear whether predictions based on genomic mutational status in single preoperative biopsies are reliable due to intra-tumoral heterogeneity. In this study we aim to investigate the reliability of genomic mutations found in single pre-operative biopsies by comparing genomic mutations to four other locations within the same tumor using next generation sequencing. Rectal cancer patients undergoing primary resection without neoadjuvant therapy were included. From each patient, one biopsy, two deep and two superficial samples were obtained and sequenced using a targeted next generation sequencing gene panel. Concordance between these five samples was assessed. In this feasibility study we included 11 patients. In 7 out of 11 (64%) patients, all 5 samples showed concordant mutations. In 4 out of 11 patients (36%) discordant mutations were observed. In conclusion, assessment of mutational status on a single pre-operative biopsy shows discordance with tumor tissue from other locations in 36% of cases. These results warrant careful interpretation of biopsy material analysis, as these might be influenced by tumor heterogeneity. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
38. Sequential ChIP-Bisulfite Sequencing Enables Direct Genome-Scale Investigation of Chromatin and DNA Methylation Cross-Talk
- Author
-
Brinkman, Arie B., Gu, Hangcang, Bartels, Stefanie J. J., Zhang, Yingying, Matarese, Filomena, Simmer, Femke, Marks, Hendrik, Bock, Christoph, Gnirke, Andreas, Meissner, Alexander, and Stunnenberg, Hendrik G.
- Abstract
Cross-talk between DNA methylation and histone modifications drives the establishment of composite epigenetic signatures and is traditionally studied using correlative rather than direct approaches. Here, we present sequential ChIP-bisulfite-sequencing (ChIP-BS-seq) as an approach to quantitatively assess DNA methylation patterns associated with chromatin modifications or chromatin-associated factors directly. A chromatin-immunoprecipitation (ChIP)-capturing step is used to obtain a restricted representation of the genome occupied by the epigenetic feature of interest, for which a single-base resolution DNA methylation map is then generated. When applied to H3 lysine 27 trimethylation (H3K27me3), we found that H3K27me3 and DNA methylation are compatible throughout most of the genome, except for CpG islands, where these two marks are mutually exclusive. Further ChIP-BS-seq-based analysis in Dnmt triple-knockout (TKO) embryonic stem cells revealed that total loss of CpG methylation is associated with alteration of H3K27me3 levels throughout the genome: H3K27me3 in localized peaks is decreased while broad local enrichments (BLOCs) of H3K27me3 are formed. At an even broader scale, these BLOCs correspond to regions of high DNA methylation in wild-type ES cells, suggesting that DNA methylation prevents H3K27me3 deposition locally and at a megabase scale. Our strategy provides a unique way of investigating global interdependencies between DNA methylation and other chromatin features., Stem Cell and Regenerative Biology
- Published
- 2012
- Full Text
- View/download PDF
39. Loss of the Putative RNA-Directed RNA Polymerase RRF-3 Makes C. elegans Hypersensitive to RNAi
- Author
-
Simmer, Femke, Tijsterman, Marcel, Parrish, Susan, Koushika, Sandhya P., Nonet, Michael L., Fire, Andrew, Ahringer, Julie, and Plasterk, Ronald H.A.
- Subjects
- *
RNA polymerases , *CAENORHABDITIS elegans genetics - Abstract
RNA interference (RNAi) is a broadly used reverse genetics method in C. elegans . Unfortunately, RNAi does not inhibit all genes . We show that loss of function of a putative RNA-directed RNA polymerase (RdRP) of C. elegans, RRF-3, results in a substantial enhancement of sensitivity to RNAi in diverse tissues. This is particularly striking in the nervous system; neurons that are generally refractory to RNAi in a wild-type genetic background can respond effectively to interference in an rrf-3 mutant background. These data provide the first indication of physiological negative modulation of the RNAi response and implicate an RdRP-related factor in this effect. The rrf-3 strain can be useful to study genes that, in wild-type, do not show a phenotype after RNAi, and it is probably the strain of choice for genome-wide RNAi screens. [Copyright &y& Elsevier]
- Published
- 2002
- Full Text
- View/download PDF
40. ERG and FLI1 binding sites demarcate targets for aberrant epigenetic regulation by AML1-ETO in acute myeloid leukemia.
- Author
-
Martens, Joost H. A., Mandoli, Amit, Simmer, Femke, Wierenga, Bart-Jan, Saeed, Sadia, Singh, Abhishek A., Altucci, Lucia, Vellenga, Edo, and Stunnenberg, Hendrik G.
- Subjects
- *
ACUTE myeloid leukemia , *FRIEND virus , *GENOMES , *HEMATOPOIETIC stem cells , *HISTONE deacetylase , *TRANSCRIPTION factors , *BINDING sites , *EPIGENETICS - Abstract
ERG an d FLU are closely related mem-bers of the ETS family of transcription factors and have been identified as essen-tial factors for the function and mainte-nance of normal hematopoietic stem cells. Here genome-wide analysis revealed that both ERG and FLI1 occupy similar genomic regions as AML1-ETO in t(8;21) AMLs and identified ERG/FLI1 as proteins that facilitate binding of oncofusion pro-tein complexes. In addition, we demonstrate that ERG and FLI1 bind the RUNX1 promoter and that shRNA-mediated si-lencing of ERG leads to reduced expres-sion of RUNX1 and AML1 -ETO, consistent with a role of ERG in transcriptional acti-vation of these proteins. Finally, we iden-tify H3 acetylation as the epigenetic mark preferentially associated with ETS factor binding. This Intimate connection be-tween ERG/FLI1 binding and H3 acetyla-tion Implies that one of the molecular strategies of oncofusion proteins, such as AML1-ETO and PML-RAR-a, involves the targeting of histone deacetylase activi-ties to ERG/FLI1 bound hematopoietic regulatory sites. Together, these results highlight the dual importance of ETS fac-tors in t(8;21) leukemogenesls, both as transcriptional regulators of the oncofu-sion protein itself as well as proteins that facilitate AML1-ETO binding. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
41. Genes Required for Systemic RNA Interference in Caenorhabditis elegans
- Author
-
Tijsterman, Marcel, May, Robin C., Simmer, Femke, Okihara, Kristy L., and Plasterk, Ronald H.A.
- Subjects
- *
RNA , *GENES , *CAENORHABDITIS elegans , *NEMATODES - Abstract
RNA interference (RNAi) in the nematode worm, Caenorhabditis elegans, occurs systemically. Double-stranded RNA (dsRNA) provided in the diet can be absorbed from the gut lumen and distributed throughout the body, triggering RNAi in tissues that are not exposed to the initial dsRNA trigger . This is in marked contrast to other animals, in which RNAi does not spread from targeted tissues to neighboring cells . Here, we report the characterization of mutants defective in the systemic aspect of RNAi, but not in the core RNAi process itself. Analysis of these mutants suggests that dsRNA uptake is a specific process involving several unique proteins. [Copyright &y& Elsevier]
- Published
- 2004
- Full Text
- View/download PDF
42. Tumor deposits should not be placed in the M category of TNM: A comparative survival analysis using SEER data.
- Author
-
Oguz Erdogan AS, Simmer F, and Nagtegaal ID
- Abstract
Tumor deposits (TD) are tumor nodules in the lymphatic drainage area of colorectal cancer patients, and they are currently classified in the N category in the TNM classification. However, due to the associated poor prognosis, some small cohort studies suggest that TD belong in the M category. A retrospective study using The Surveillance, Epidemiology, and End Results program (SEER) data was performed in Stages III and IV colon carcinoma (CC) patients to evaluate the prognostic impact of TD. In multivariate analysis, TD have significantly negative effect on survival in both stages (Stage III HR = 1.4 [95% CI 1.4-1.5] and Stage IV HR = 1.3 [95% CI 1.2-1.3]). In Stage III, 5-year overall survival (OS) for patients with TD 49%, whereas it was 64% for patients without TD (p < .001). Additionally, in Stage IV patients without TD, the 5-year OS rates are superior at 21% compared to patients with TD, who show 5-year OS rate of 10% (p < .001). Stage III patients with TD (5-year OS 49%) have a significantly better prognosis compared to Stage IV patients (5-year OS 17%, p < .001). Therefore, despite the previous suggestions, this large scale study (n = 52,332) on outcomes in CC does not support the classification of TD in Stage IV., (© 2024 The Author(s). International Journal of Cancer published by John Wiley & Sons Ltd on behalf of UICC.)
- Published
- 2024
- Full Text
- View/download PDF
43. Clonal Patterns Between Pouch Neoplasia and Prior Colorectal Neoplasia in Inflammatory Bowel Disease Patients: An Exploratory Cohort Study.
- Author
-
Te Groen M, Derikx LAAP, van Lierop L, Ylstra B, Hoentjen F, Nagtegaal ID, and Simmer F
- Subjects
- Humans, Cohort Studies, Colorectal Neoplasms etiology, Inflammatory Bowel Diseases complications
- Published
- 2023
- Full Text
- View/download PDF
44. Improving tumor budding reporting in colorectal cancer: a Delphi consensus study.
- Author
-
Haddad TS, Lugli A, Aherne S, Barresi V, Terris B, Bokhorst JM, Brockmoeller SF, Cuatrecasas M, Simmer F, El-Zimaity H, Fléjou JF, Gibbons D, Cathomas G, Kirsch R, Kuhlmann TP, Langner C, Loughrey MB, Riddell R, Ristimäki A, Kakar S, Sheahan K, Treanor D, van der Laak J, Vieth M, Zlobec I, and Nagtegaal ID
- Subjects
- Biopsy, Cell Differentiation, Consensus, Delphi Technique, Humans, Neoplasm Invasiveness, Neoplasm Staging, Predictive Value of Tests, Carcinoma pathology, Cell Movement, Colonic Polyps pathology, Colorectal Neoplasms pathology, Pathology, Clinical standards
- Abstract
Tumor budding is a long-established independent adverse prognostic marker in colorectal cancer, yet methods for its assessment have varied widely. In an effort to standardize its reporting, a group of experts met in Bern, Switzerland, in 2016 to reach consensus on a single, international, evidence-based method for tumor budding assessment and reporting (International Tumor Budding Consensus Conference [ITBCC]). Tumor budding assessment using the ITBCC criteria has been validated in large cohorts of cancer patients and incorporated into several international colorectal cancer pathology and clinical guidelines. With the wider reporting of tumor budding, new issues have emerged that require further clarification. To better inform researchers and health-care professionals on these issues, an international group of experts in gastrointestinal pathology participated in a modified Delphi process to generate consensus and highlight areas requiring further research. This effort serves to re-affirm the importance of tumor budding in colorectal cancer and support its continued use in routine clinical practice., (© 2021. The Author(s).)
- Published
- 2021
- Full Text
- View/download PDF
45. RNF43 mutation analysis in serrated polyposis, sporadic serrated polyps and Lynch syndrome polyps.
- Author
-
van Herwaarden YJ, Koggel LM, Simmer F, Vink-Börger EM, Dura P, Meijer GA, Nagengast FM, Hoogerbrugge N, Bisseling TM, and Nagtegaal ID
- Subjects
- Adult, Aged, Cohort Studies, Colon pathology, Colorectal Neoplasms etiology, DNA Mutational Analysis, Diagnosis, Differential, Female, Humans, Male, Microsatellite Instability, Middle Aged, Mutation, Wnt Signaling Pathway, Colonic Neoplasms diagnosis, Colonic Neoplasms genetics, Colonic Neoplasms pathology, Colonic Polyps diagnosis, Colonic Polyps genetics, Colonic Polyps pathology, Colorectal Neoplasms, Hereditary Nonpolyposis diagnosis, Colorectal Neoplasms, Hereditary Nonpolyposis genetics, Colorectal Neoplasms, Hereditary Nonpolyposis pathology, Ubiquitin-Protein Ligases analysis, Ubiquitin-Protein Ligases genetics
- Abstract
Aims: RNF43 is suggested to be involved in the serrated pathway towards colorectal cancer and encodes a transmembrane Ring-type E3 ubiquitin ligase that negatively regulates the Wnt pathway. This study aimed to elucidate the role of RNF43 gene variants in serrated polyposis syndrome (SPS) and serrated polyps., Methods and Results: Three cohorts were tested. The first cohort included germline DNA of 26 SPS patients tested for pathogenic variants in RNF43 by Sanger sequencing all exons. In the second cohort we tested somatic DNA for RNF43 mutations from sporadic serrated lesions: 25 hyperplastic polyps, 35 sessile serrated lesions and 38 traditional serrated adenomas (TSA). In the third cohort we investigated RNF43 mutations in 49 serrated polyps and 60 conventional adenomas from 40 patients with Lynch syndrome. No germline RNF43 pathogenic variants were detected in our SPS cohort. In sporadic colorectal lesions we detected RNF43 deleterious frameshift mutations in three TSA and one SSL. The RNF43 mutations in previously described homopolymeric hot-spots were detected in microsatellite-instable (MSI) polyps and the other RNF43 mutations in microsatellite-stable (MSS) serrated polyps. RNF43 hot-spot mutations were discovered in seven serrated polyps and 12 conventional adenomas from Lynch patients., Conclusion: Truncating germline RNF43 mutations are uncommon in SPS patients. Somatic mutations in RNF43 were found in sporadic TSA and SSL and both serrated polyps and adenomas from Lynch syndrome patients, suggesting that they do not develop early in the pathway to CRC and are not specific for serrated polyp subtypes., (© 2020 The Authors. Histopathology published by John Wiley & Sons Ltd.)
- Published
- 2021
- Full Text
- View/download PDF
46. Colorectal metastasis to the gallbladder mimicking a primary gallbladder malignancy: histopathological and molecular characteristics.
- Author
-
de Bitter TJJ, van der Linden RLA, van Vliet S, Weren F, Sie D, Ylstra B, van der Linden HC, Knijn N, Ligtenberg MJL, van der Post RS, Simmer F, and Nagtegaal ID
- Subjects
- Adenocarcinoma diagnosis, Adenocarcinoma genetics, Aged, Aged, 80 and over, Colorectal Neoplasms diagnosis, Colorectal Neoplasms genetics, DNA Mutational Analysis, Diagnosis, Differential, Female, Gallbladder Neoplasms diagnosis, Gallbladder Neoplasms genetics, Humans, Male, Middle Aged, Adenocarcinoma secondary, Biomarkers, Tumor analysis, Colorectal Neoplasms pathology, Gallbladder Neoplasms secondary
- Abstract
Aims: Outcomes of colorectal cancer (CRC) treatment and survival have steadily improved during the past decades, accompanied by an increased risk of developing second primary tumours and metastatic tumours at unusual sites. Metastatic CRC can show mucosal colonisation, thereby mimicking a second primary tumour. This potential confusion could lead to incorrect diagnosis and consequently inadequate treatment of the patient. The aim of this study was to differentiate between metastatic CRC and a second primary (gallbladder cancer, GBC) using a combination of standard histopathology and molecular techniques., Methods and Results: Ten consecutive patients with both CRC and GBC were identified in our region using the Dutch National Pathology Archive (PALGA). Two patients served as negative controls. Histology of GBC was reviewed by nine pathologists. A combination of immunohistochemistry, microsatellite analysis, genomewide DNA copy number analysis and targeted somatic mutation analysis was used to aid in differential diagnosis. In two patients, CRC and GBC were clonally related, as confirmed by somatic mutation analysis. For one case, this was confirmed by genomewide DNA copy number analysis. However, in both cases, pathologists initially considered the GBC as a second primary tumour., Conclusions: Metastatic CRC displaying mucosal colonisation is often misinterpreted as a second primary tumour. A combination of traditional histopathology and molecular techniques improves this interpretation, and lowers the risk of inadequate treatment., (© 2019 The Authors. Histopathology Published by John Wiley & Sons Ltd.)
- Published
- 2019
- Full Text
- View/download PDF
47. Quantification and localization of oncogenic receptor tyrosine kinase variant transcripts using molecular inversion probes.
- Author
-
van den Heuvel CNAM, Das AI, de Bitter T, Simmer F, Wurdinger T, Molina-Vila MA, and Leenders WPJ
- Subjects
- Animals, Humans, In Situ Hybridization, Mice, Molecular Diagnostic Techniques, Organ Specificity, Molecular Probes, Oncogenes, Receptor Protein-Tyrosine Kinases genetics, Transcription, Genetic
- Abstract
Oncogenic membrane receptor tyrosine kinases such as MET and EGFR, or auto-active variants thereof, are important targets for cancer precision therapy. Targeted inhibition of these oncogenic receptors however invariably leads to resistance, resulting from acquisition of resistance-inducing mutations or from selective outgrowth of a priori resistant tumour cells. Most applied molecular protocols cannot distinguish between intracellular and intercellular heterogeneity of oncogene (variant) expression, which may lead to misinterpretation of the molecular make-up of a cancer and suboptimal application of targeted therapies. We here combined two related techniques to allow semiquantitative and localized in situ detection of specific transcript splice variants using single molecule molecular inversion probe (smMIP)-based next generation sequencing and padlock probe-based rolling circle amplification, respectively. We show highly specific padlock probe-based multiplex detection of MET, MET
Δ7-8 and METΔ14 transcripts, lacking exons 7-8 and exon 14 respectively, and of EGFR and the auto-active EGFRvIII, lacking exons 2-7. The combination of quantitative transcript variant detection with smMIPs and transcript localization using padlock probes can be used for detection of oncogenic transcripts on the single-cell level, allowing study of tumour heterogeneity. Visualization of tumour heterogeneity can shed light on the biology underlying drug resistance and potentially improve targeted therapeutics.- Published
- 2018
- Full Text
- View/download PDF
48. Incidence and origin of histologically confirmed liver metastases: an explorative case-study of 23,154 patients.
- Author
-
de Ridder J, de Wilt JH, Simmer F, Overbeek L, Lemmens V, and Nagtegaal I
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Child, Child, Preschool, Female, Humans, Incidence, Infant, Liver Neoplasms epidemiology, Male, Middle Aged, Young Adult, Liver Neoplasms secondary
- Abstract
Background: The liver is a common metastatic site for a large variety of primary tumors. For both patients with known and unknown primary tumors it is important to understand metastatic patterns to provide tailored therapies., Objective: To perform a nationwide exploration of the origins of histological confirmed liver metastases., Results: A total of 23,154 patients were identified. The majority of liver metastases were carcinomas (n=21,400; 92%) of which adenocarcinoma was the most frequent subtype (n=17,349; 75%). Most common primary tumors in patients with adenocarcinoma were from colorectal (n=8,004), pancreatic (n=1,755) or breast origin (n=1,415). In women of 50 years and younger, metastatic adenocarcinoma originated more frequently from breast cancer, while in women older than 70 years liver metastases originated more frequently from gastrointestinal tumors. Liver metastases in men older than 70 years originated often from squamous cell lung carcinoma. An unknown primary tumor was detected in 4,209 (18%) patients, although tumor type could be determined in 3,855 (92%) of them., Methods: Data were collected using the nationwide network and registry of histo- and cytopathology in the Netherlands (PALGA). All histological confirmed liver metastases between January 2001 and December 2010 were evaluated for tumor type, origin of the primary tumor and were correlated with patient characteristics (age, gender)., Conclusion: The current study provides an overview of the origins of liver metastases in a series of 23,154 patients.
- Published
- 2016
- Full Text
- View/download PDF
49. Reduced rate of copy number aberrations in mucinous colorectal carcinoma.
- Author
-
Hugen N, Simmer F, Mekenkamp LJ, Koopman M, van den Broek E, de Wilt JH, Punt CJ, Ylstra B, Meijer GA, and Nagtegaal ID
- Subjects
- Adenocarcinoma, Mucinous mortality, Adenocarcinoma, Mucinous pathology, Adenocarcinoma, Mucinous therapy, Chromosomal Instability, Chromosomes, Human, Pair 18, Chromosomes, Human, Pair 20, Clinical Trials, Phase III as Topic, Colorectal Neoplasms mortality, Colorectal Neoplasms pathology, Colorectal Neoplasms therapy, Databases, Genetic, Genetic Predisposition to Disease, Humans, Kaplan-Meier Estimate, Phenotype, Proportional Hazards Models, Randomized Controlled Trials as Topic, Risk Factors, Time Factors, Adenocarcinoma, Mucinous genetics, Biomarkers, Tumor genetics, Colorectal Neoplasms genetics, DNA Copy Number Variations, Gene Dosage
- Abstract
Background: Mucinous carcinoma (MC) is found in 10%-15% of colorectal cancer (CRC) patients. It differs from the common adenocarcinoma (AC) in histopathological appearance and clinical behavior., Methods: Genome-wide DNA copy number and survival data from MC and AC primary CRC samples from patients from two phase III trials (CAIRO and CAIRO2) was compared. Chromosomal copy number data from The Cancer Genome Atlas (TCGA) was used for validation. Altogether, 470 ACs were compared to 57 MCs., Results: MC showed a reduced amount of copy number aberrations (CNAs) compared with AC for the CAIRO/CAIRO2 cohort, with a median amount of CNAs that was 1.5-fold lower (P = 0.002). Data from TCGA also showed a reduced amount of CNAs for MC. MC samples in both cohorts displayed less gain at chromosome 20q and less loss of chromosome 18p. A high rate of chromosomal instability was a strong negative prognostic marker for survival in MC patients from the CAIRO cohorts (hazard ratio 15.60, 95% CI 3.24-75.05)., Conclusions: Results from this study indicate that the distinct MC phenotype is accompanied by a different genetic basis when compared with AC and show a strong association between the rate of chromosomal instability and survival in MC patients.
- Published
- 2015
- Full Text
- View/download PDF
50. MicroRNA-143 is a putative predictive factor for the response to fluoropyrimidine-based chemotherapy in patients with metastatic colorectal cancer.
- Author
-
Simmer F, Venderbosch S, Dijkstra JR, Vink-Börger EM, Faber C, Mekenkamp LJ, Koopman M, De Haan AF, Punt CJ, and Nagtegaal ID
- Subjects
- Biomarkers, Tumor, Camptothecin administration & dosage, Camptothecin analogs & derivatives, Capecitabine administration & dosage, Clinical Trials, Phase III as Topic, Colorectal Neoplasms metabolism, Colorectal Neoplasms pathology, Disease-Free Survival, Drug Resistance, Neoplasm, Female, Humans, Immunohistochemistry, Irinotecan, Male, MicroRNAs genetics, Multicenter Studies as Topic, Neoplasm Metastasis, Organoplatinum Compounds administration & dosage, Oxaliplatin, Randomized Controlled Trials as Topic, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Colorectal Neoplasms drug therapy, Colorectal Neoplasms genetics, MicroRNAs biosynthesis
- Abstract
Approximately half of the colorectal cancer (CRC) patients develop metastatic disease. Fluoropyrimidine-based chemotherapy forms the backbone of treatment in these patients. However, the response to this therapy varies between individuals. Therefore, an important challenge in CRC research is to identify biomarkers that are predictive of this response. In this study, we explored the potential of miRNAs, and the miRNA producing protein Dicer, as biomarkers that can predict chemo-sensitivity to fluoropyrimidine chemotherapy in patients with metastatic colorectal cancer (mCRC). We analyzed the levels of 22 miRNAs and the Dicer protein in primary tumors from patients with mCRC who were treated with first-line capecitabine monotherapy within the CAIRO trial of the Dutch Colorectal Cancer Group. Correlation between the expression status of miRNAs or Dicer in primary tumors and the progression free survival (PFS) were investigated. Patients with low expression of miR-143 in their primary tumor had increased median PFS compared to those with high expression of miR-143. Furthermore, FXYD3, an ion transport regulator and a putative target of miR-143, also showed an association with PFS. These findings warrant further studies to investigate the relationship between miR-143, FXYD3 and fluoropyrimidines, and the clinical utility of miR-143 as biomarker.
- Published
- 2015
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.